Document Detail


It is the time to ask what adenosine can do for cardioprotection in ischemic heart disease.
MedLine Citation:
PMID:  10361900     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
M Kitakaze
Publication Detail:
Type:  Comment; Editorial    
Journal Detail:
Title:  Internal medicine (Tokyo, Japan)     Volume:  38     ISSN:  0918-2918     ISO Abbreviation:  Intern. Med.     Publication Date:  1999 Apr 
Date Detail:
Created Date:  1999-07-29     Completed Date:  1999-07-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9204241     Medline TA:  Intern Med     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  305-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine / therapeutic use*
Cardiovascular Agents / therapeutic use*
Humans
Myocardial Ischemia / drug therapy,  prevention & control*
Vasodilator Agents / therapeutic use*
Chemical
Reg. No./Substance:
0/Cardiovascular Agents; 0/Vasodilator Agents; 58-61-7/Adenosine
Comments/Corrections
Comment On:
Intern Med. 1999 Apr;38(4):324-9   [PMID:  10361904 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of surgery in occult gastrointestinal bleeding.
Next Document:  Carbonyl stress in the pathogenesis of diabetic nephropathy.